Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.9NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.2.6NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GD.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBZNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BR.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.79NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.14NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.42NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
K.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JN.1.56NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JN.1.41NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KF.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.4.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
ANNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JN.1.48.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BN.1.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BU.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BQ.1.10NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.38NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DT.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DS.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.63NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DU.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.53NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BF.7.4.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
XBB.1.15NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.47NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.13NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BN.1.10NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.23NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GA.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.58NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GH.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BN.1.2.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.96NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EZ.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EW.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.18NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BE.13NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BW.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FB.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.23NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BF.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BQ.1.12NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BF.7.15NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used